These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22003912)

  • 1. Biomarkers for antiepileptic drug response.
    Glauser TA
    Biomark Med; 2011 Oct; 5(5):635-41. PubMed ID: 22003912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical impact of pharmacogenetics on the treatment of epilepsy.
    Löscher W; Klotz U; Zimprich F; Schmidt D
    Epilepsia; 2009 Jan; 50(1):1-23. PubMed ID: 18627414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacogenetics and potential application in personalized medicine.
    Zhou SF; Di YM; Chan E; Du YM; Chow VD; Xue CC; Lai X; Wang JC; Li CG; Tian M; Duan W
    Curr Drug Metab; 2008 Oct; 9(8):738-84. PubMed ID: 18855611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic profile of patients with epilepsy on first-line antiepileptic drugs and potential directions for personalized treatment.
    Grover S; Gourie-Devi M; Baghel R; Sharma S; Bala K; Gupta M; Narayanasamy K; Varma B; Gupta M; Kaur K; Talwar P; Kaur H; Giddaluru S; Sharma A; Brahmachari SK; Indian Genome Variation Consortium ; Kukreti R
    Pharmacogenomics; 2010 Jul; 11(7):927-41. PubMed ID: 20602612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cytochrome P-450 2C9/2C19 but not the ABCB1 genetic polymorphism may be associated with the liver cytochrome 3A4 induction by phenytoin.
    Chhun S; Verstuyft C; Rizzo-Padoin N; Simoneau G; Becquemont L; Bergmann JF; Mouly S
    J Clin Psychopharmacol; 2012 Jun; 32(3):429-31. PubMed ID: 22561479
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of polymorphisms in six candidate genes on phenytoin maintenance therapy in Han Chinese patients.
    Hung CC; Huang HC; Gao YH; Chang WL; Ho JL; Chiou MH; Hsieh YW; Liou HH
    Pharmacogenomics; 2012 Sep; 13(12):1339-49. PubMed ID: 22966884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYP2C9, CYP2C19, and ABCB1 genotype and hospitalization for phenytoin toxicity.
    Hennessy S; Leonard CE; Freeman CP; Metlay JP; Chu X; Strom BL; Bilker WB
    J Clin Pharmacol; 2009 Dec; 49(12):1483-7. PubMed ID: 19617466
    [No Abstract]   [Full Text] [Related]  

  • 8. The ABCB1, ABCC2 and RALBP1 polymorphisms are associated with carbamazepine response in epileptic patient: a systematic review.
    Boughrara W; Chentouf A
    Acta Neurol Belg; 2022 Aug; 122(4):871-880. PubMed ID: 35325436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-response to antiepileptic pharmacotherapy is associated with the ABCC2 -24C>T polymorphism in young and adult patients with epilepsy.
    Ufer M; Mosyagin I; Muhle H; Jacobsen T; Haenisch S; Häsler R; Faltraco F; Remmler C; von Spiczak S; Kroemer HK; Runge U; Boor R; Stephani U; Cascorbi I
    Pharmacogenet Genomics; 2009 May; 19(5):353-62. PubMed ID: 19415824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction analysis between genetic polymorphisms and pharmacodynamic effect in patients treated with adjunctive cilostazol to dual antiplatelet therapy: results of the ACCEL-TRIPLE (Accelerated Platelet Inhibition by Triple Antiplatelet Therapy According to Gene Polymorphism) study.
    Kim IS; Jeong YH; Park Y; Yoon SE; Kwon TJ; Park JR; Hwang SJ; Koh EH; Kwak CH; Hwang JY; Kim S
    Br J Clin Pharmacol; 2012 Apr; 73(4):629-40. PubMed ID: 22007612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenobarbital-induced severe cutaneous adverse drug reactions are associated with CYP2C19*2 in Thai children.
    Manuyakorn W; Siripool K; Kamchaisatian W; Pakakasama S; Visudtibhan A; Vilaiyuk S; Rujirawat T; Benjaponpitak S
    Pediatr Allergy Immunol; 2013 May; 24(3):299-303. PubMed ID: 23551241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personalized medicine approaches in epilepsy.
    Walker LE; Mirza N; Yip VLM; Marson AG; Pirmohamed M
    J Intern Med; 2015 Feb; 277(2):218-234. PubMed ID: 25338670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurological toxicity after phenytoin infusion in a pediatric patient with epilepsy: influence of CYP2C9, CYP2C19 and ABCB1 genetic polymorphisms.
    Dorado P; López-Torres E; Peñas-Lledó EM; Martínez-Antón J; Llerena A
    Pharmacogenomics J; 2013 Aug; 13(4):359-61. PubMed ID: 22641027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic predictors of the maximum doses patients receive during clinical use of the anti-epileptic drugs carbamazepine and phenytoin.
    Tate SK; Depondt C; Sisodiya SM; Cavalleri GL; Schorge S; Soranzo N; Thom M; Sen A; Shorvon SD; Sander JW; Wood NW; Goldstein DB
    Proc Natl Acad Sci U S A; 2005 Apr; 102(15):5507-12. PubMed ID: 15805193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial: a pharmacogenetic analysis.
    Mega JL; Close SL; Wiviott SD; Shen L; Walker JR; Simon T; Antman EM; Braunwald E; Sabatine MS
    Lancet; 2010 Oct; 376(9749):1312-9. PubMed ID: 20801494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacogenetics and pharmacodynamics of clopidogrel response: an analysis from the PRINC (Plavix Response in Coronary Intervention) trial.
    Gladding P; Webster M; Zeng I; Farrell H; Stewart J; Ruygrok P; Ormiston J; El-Jack S; Armstrong G; Kay P; Scott D; Gunes A; Dahl ML
    JACC Cardiovasc Interv; 2008 Dec; 1(6):620-7. PubMed ID: 19463375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of polymorphisms of CYP2C9, CYP2C19, and ABCB1, and activity of P-glycoprotein with response to anti-epileptic drugs.
    Taur SR; Kulkarni NB; Gandhe PP; Thelma BK; Ravat SH; Gogtay NJ; Thatte UM
    J Postgrad Med; 2014; 60(3):265-9. PubMed ID: 25121365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous drug reactions to antiepileptic drugs and relation with HLA alleles in the Turkish population.
    Büyüköztürk S; Kekik Ç; Gökyiğit AZ; Tezer Filik FI; Karakaya G; Saygi S; Dursun AB; Kirbaş S; Tüfekçi A; Sin AZ; Aydoğdu I; Sorgun MH; Aydin N; Gelincik A; Çolakoğlu B; Çelik G; Oğuz F
    Eur Ann Allergy Clin Immunol; 2018 Jan; 50(1):36-41. PubMed ID: 29350020
    [No Abstract]   [Full Text] [Related]  

  • 19. [Development of rapid genotyping methods for single nucleotide polymorphisms of cytochrome P450 2C9 (CYP2C9) and cytochrome P450 2C19 (CYP2C19) and their clinical application in pediatric patients with epilepsy].
    Yamamoto Y; Takahashi Y; Nishimura S; Ikumi Y; Mishima N; Kagawa Y
    Yakugaku Zasshi; 2011; 131(5):809-15. PubMed ID: 21532277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HLA-B*15:02 polymorphism and Tegretol
    Chouchi M; Kaabachi W; Tizaoui K; Daghfous R; Aidli SE; Hila L
    Rev Neurol (Paris); 2018 May; 174(5):278-291. PubMed ID: 29685430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.